SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Senetek PLC (ADRs)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: pete embach1 who wrote (25)1/30/1997 9:06:00 PM
From: Ray   of 36
 
As far as I know drug approval will be around the middle
of this year for most of europe.The approval for the
U.S. will be either at the end of this year or the
beginning of next.The drug protocol used in the clinical
trials will meet all the american FDA's standards.
I believe their impotence drug combination is better
than anything else on the market.They are not using
ProstaglandinE1.Their drug gives a more natural sexual
experience.
Don't sell this stock under $10.00.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News